menu toggle
Independence Day
Cencora will be closed in observance of the Independence Day holiday and there will be no deliveries on Thursday, July 4. Our Customer Service and Customer Systems Support teams will also be unavailable on this day. Please review our full holiday schedule for more detailed information and to plan your orders accordingly. We will resume normal operations on Friday, July 5.

May 10, 2024

Now available DOCIVYX

DOCIVYX (docetaxel) is a microtubule inhibitor indicated for:
  • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC
  • Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC
  • Castration-Resistant Prostate Cancer (CRPC): with prednisone in metastatic CRPC
  • Gastric Adenocarcinoma (GC): with cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN
Please see full prescribing information here.